METHODS AND COMPOSITIONS FOR TREATING CANCER IN TAXANE-RESISTANT PATIENTS
Methods and compositions are provided for treating cancer in a taxane-resistant patient, comprising administering an effective dose of a taxane simultaneously or sequentially with a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof. Also provided are methods and composi...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VAN DER PUTTEN, Eric FREUND, Colin |
| description | Methods and compositions are provided for treating cancer in a taxane-resistant patient, comprising administering an effective dose of a taxane simultaneously or sequentially with a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof. Also provided are methods and compositions for reversing taxane resistance in a patient, comprising administering an effective dose of a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof.
L'invention concerne des méthodes et des compositions pour le traitement du cancer chez un patient résistant au taxane, comprenant l'administration d'une dose efficace d'un taxane simultanément ou séquentiellement avec un inhibiteur de P-gp, tel que le ritonavir ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également des méthodes et des compositions pour inverser la résistance au taxane chez un patient, comprenant l'administration d'une dose efficace d'un inhibiteur de P-gp, tel que le ritonavir ou un sel pharmaceutiquement acceptable de celui-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023152370A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023152370A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023152370A13</originalsourceid><addsrcrecordid>eNqNyrEKwkAMANAuDqL-Q8C50N4hzuGa2gxNyl3AbqXIOYkW6v-jgx_g9Ja3Lbgn67RJgNJA0H7QxMYqCVqNYJHQWC4QUAJFYAHDEYXKSImToRgM30FiaV9s7vNjzYefu-LYkoWuzMtryusy3_Izv6erusr5-uT8ucLa_7c-AMYuOw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS AND COMPOSITIONS FOR TREATING CANCER IN TAXANE-RESISTANT PATIENTS</title><source>esp@cenet</source><creator>VAN DER PUTTEN, Eric ; FREUND, Colin</creator><creatorcontrib>VAN DER PUTTEN, Eric ; FREUND, Colin</creatorcontrib><description>Methods and compositions are provided for treating cancer in a taxane-resistant patient, comprising administering an effective dose of a taxane simultaneously or sequentially with a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof. Also provided are methods and compositions for reversing taxane resistance in a patient, comprising administering an effective dose of a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof.
L'invention concerne des méthodes et des compositions pour le traitement du cancer chez un patient résistant au taxane, comprenant l'administration d'une dose efficace d'un taxane simultanément ou séquentiellement avec un inhibiteur de P-gp, tel que le ritonavir ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également des méthodes et des compositions pour inverser la résistance au taxane chez un patient, comprenant l'administration d'une dose efficace d'un inhibiteur de P-gp, tel que le ritonavir ou un sel pharmaceutiquement acceptable de celui-ci.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230817&DB=EPODOC&CC=WO&NR=2023152370A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230817&DB=EPODOC&CC=WO&NR=2023152370A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VAN DER PUTTEN, Eric</creatorcontrib><creatorcontrib>FREUND, Colin</creatorcontrib><title>METHODS AND COMPOSITIONS FOR TREATING CANCER IN TAXANE-RESISTANT PATIENTS</title><description>Methods and compositions are provided for treating cancer in a taxane-resistant patient, comprising administering an effective dose of a taxane simultaneously or sequentially with a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof. Also provided are methods and compositions for reversing taxane resistance in a patient, comprising administering an effective dose of a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof.
L'invention concerne des méthodes et des compositions pour le traitement du cancer chez un patient résistant au taxane, comprenant l'administration d'une dose efficace d'un taxane simultanément ou séquentiellement avec un inhibiteur de P-gp, tel que le ritonavir ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également des méthodes et des compositions pour inverser la résistance au taxane chez un patient, comprenant l'administration d'une dose efficace d'un inhibiteur de P-gp, tel que le ritonavir ou un sel pharmaceutiquement acceptable de celui-ci.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwkAMANAuDqL-Q8C50N4hzuGa2gxNyl3AbqXIOYkW6v-jgx_g9Ja3Lbgn67RJgNJA0H7QxMYqCVqNYJHQWC4QUAJFYAHDEYXKSImToRgM30FiaV9s7vNjzYefu-LYkoWuzMtryusy3_Izv6erusr5-uT8ucLa_7c-AMYuOw</recordid><startdate>20230817</startdate><enddate>20230817</enddate><creator>VAN DER PUTTEN, Eric</creator><creator>FREUND, Colin</creator><scope>EVB</scope></search><sort><creationdate>20230817</creationdate><title>METHODS AND COMPOSITIONS FOR TREATING CANCER IN TAXANE-RESISTANT PATIENTS</title><author>VAN DER PUTTEN, Eric ; FREUND, Colin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023152370A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VAN DER PUTTEN, Eric</creatorcontrib><creatorcontrib>FREUND, Colin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VAN DER PUTTEN, Eric</au><au>FREUND, Colin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS AND COMPOSITIONS FOR TREATING CANCER IN TAXANE-RESISTANT PATIENTS</title><date>2023-08-17</date><risdate>2023</risdate><abstract>Methods and compositions are provided for treating cancer in a taxane-resistant patient, comprising administering an effective dose of a taxane simultaneously or sequentially with a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof. Also provided are methods and compositions for reversing taxane resistance in a patient, comprising administering an effective dose of a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof.
L'invention concerne des méthodes et des compositions pour le traitement du cancer chez un patient résistant au taxane, comprenant l'administration d'une dose efficace d'un taxane simultanément ou séquentiellement avec un inhibiteur de P-gp, tel que le ritonavir ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également des méthodes et des compositions pour inverser la résistance au taxane chez un patient, comprenant l'administration d'une dose efficace d'un inhibiteur de P-gp, tel que le ritonavir ou un sel pharmaceutiquement acceptable de celui-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023152370A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | METHODS AND COMPOSITIONS FOR TREATING CANCER IN TAXANE-RESISTANT PATIENTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A02%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VAN%20DER%20PUTTEN,%20Eric&rft.date=2023-08-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023152370A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |